Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $21.39 $36.72
52 weeks $20.67 $41.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Mar 05, 2020 $35.98 $36.94 $35.14 $35.59 1 167 162
Mar 04, 2020 $35.99 $37.00 $35.09 $36.93 1 162 884
Mar 03, 2020 $35.70 $37.15 $34.77 $35.15 1 443 456
Mar 02, 2020 $35.37 $36.10 $34.08 $35.50 1 356 807
Feb 28, 2020 $34.81 $35.60 $33.64 $35.36 2 010 133
Feb 27, 2020 $35.07 $37.80 $34.40 $36.00 2 247 868
Feb 26, 2020 $34.24 $37.00 $34.01 $36.06 2 292 752
Feb 25, 2020 $37.00 $37.57 $33.99 $34.12 1 757 170
Feb 24, 2020 $37.00 $38.10 $35.73 $36.39 1 655 988
Feb 21, 2020 $39.68 $39.76 $37.80 $38.49 1 057 079
Feb 20, 2020 $39.90 $40.25 $38.11 $39.74 1 815 476
Feb 19, 2020 $40.99 $41.88 $39.89 $39.93 842 449
Feb 18, 2020 $40.50 $41.24 $39.93 $40.55 986 497
Feb 14, 2020 $40.59 $41.57 $40.49 $41.27 1 023 495
Feb 13, 2020 $42.17 $42.41 $40.98 $41.05 915 635
Feb 12, 2020 $41.80 $42.81 $41.34 $42.41 1 013 586
Feb 11, 2020 $43.25 $43.69 $41.05 $41.58 1 248 638
Feb 10, 2020 $40.35 $43.30 $39.61 $42.85 1 576 643
Feb 07, 2020 $40.86 $41.14 $40.05 $40.43 1 345 013
Feb 06, 2020 $46.01 $46.42 $40.15 $41.10 4 085 185
Feb 05, 2020 $44.80 $45.25 $42.95 $43.72 1 343 069
Feb 04, 2020 $44.20 $45.09 $43.72 $43.90 1 311 606
Feb 03, 2020 $42.36 $44.69 $42.25 $43.26 1 686 568
Jan 31, 2020 $41.27 $42.50 $40.90 $41.91 1 521 888
Jan 30, 2020 $43.74 $44.33 $41.06 $41.52 2 119 536
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT